Survival after second-look laparotomy in advanced ovarian epithelial cancer

Smith, 1976, Second-look operation in ovarian carcinoma, Cancer, 38, 1438, 10.1002/1097-0142(197609)38:3<1438::AID-CNCR2820380351>3.0.CO;2-2

Gershenson, 1985, Prognosis of surgically determined complete responders in advanced ovarian cancer, Cancer, 55, 1129, 10.1002/1097-0142(19850301)55:5<1129::AID-CNCR2820550531>3.0.CO;2-O

Raju, 1982, Second-look operations in the planned management of advanced ovarian carcinoma, Am J Obstet Gynecol, 144, 650, 10.1016/0002-9378(82)90432-X

Miller, 1986, A critical reassessment of second-look laparotomy in epithelial ovarian cancer, Cancer, 57, 530, 10.1002/1097-0142(19860201)57:3<530::AID-CNCR2820570321>3.0.CO;2-5

Ozols, 1985, The case for combination chemotherapy in the treatment of advanced ovarian cancer, J Clin Oncol, 3, 1445, 10.1200/JCO.1985.3.11.1445

Neijt, 1986, Complete remission at laparotomy: still a gold standard in ovarian cancer?, Lancet, 1, 1028, 10.1016/S0140-6736(86)91290-0

Cohen, 1983, Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)—the Mount Sinai experience, Clin Obstet Gynaecol, 10, 307, 10.1016/S0306-3356(21)00571-9

Copeland, 1985, Microscopic disease at second-look laparotomy in advanced ovarian cancer, Cancer, 55, 472, 10.1002/1097-0142(19850115)55:2<472::AID-CNCR2820550231>3.0.CO;2-A

de Gramont, 1985, Adriamycin and cis-platinum in advanced ovarian cancer, Eur J Cancer Clin Oncol, 21, 665, 10.1016/0277-5379(85)90262-7

de Gramont, 1986, La chimiothérapie dans 143 cancers épithéliaux avancés de l'ovaire, J Gynecol Obstet Biol Reprod, 15, 105

Dauplat, 1986, Second-look laparotomy in managing epithelial ovarian carcinoma, Cancer, 57, 1627, 10.1002/1097-0142(19860415)57:8<1627::AID-CNCR2820570831>3.0.CO;2-D

Louie, 1986, Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma, J Clin Oncol, 4, 1579, 10.1200/JCO.1986.4.11.1579

Neijt, 1984, Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs. CHAP-5) in advanced ovarian carcinoma, Lancet, ii, 594, 10.1016/S0140-6736(84)90594-4

Pasmantier, 1985, Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens, Cancer Treat Rep, 69, 689

Steiner, 1985, Multimodal approach (surgery, chemotherapy and radiotherapy) in the treatment of advanced ovarian carcinoma, Cancer, 55, 2748, 10.1002/1097-0142(19850615)55:12<2748::AID-CNCR2820551203>3.0.CO;2-F

Wils, 1986, Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III–IV epithelial ovarian carcinoma, J Clin Oncol, 4, 1068, 10.1200/JCO.1986.4.7.1068

Schwartz, 1983, Current status of the second-look operation in ovarian cancer, Clin Obstet Gynaecol, 10, 245, 10.1016/S0306-3356(21)00567-7

Ho, 1987, A reassessment of the role of second-look laparotomy in advanced ovarian cancer, J Clin Oncol, 5, 1316, 10.1200/JCO.1987.5.9.1316

Goldhirsch, 1988, Treatment of advanced ovarian cancer with surgery, chemotherapy, and consolidation of response by whole-abdominal radiotherapy, Cancer, 62, 40, 10.1002/1097-0142(19880701)62:1<40::AID-CNCR2820620110>3.0.CO;2-O

Berek, 1983, Survival of patients following secondary cytoreductive surgery in ovarian cancer, Obstet Gynecol, 61, 189

Lippman, 1988, Second-look laparotomy in epithelial ovarian carcinoma, Cancer, 61, 2571, 10.1002/1097-0142(19880615)61:12<2571::AID-CNCR2820611231>3.0.CO;2-O

Pater, 1987, Second-line chemotherapy of stage III–IV ovarian carcinoma: a randomized comparison of melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin, Cancer Treat Rep, 71, 277

de Gramont, 1984, La chimiothérapie de seconde ligne du cancer de l'ovaire, Union Med Can, 113, 940

Hacker, 1985, Whole abdominal radiation as salvage therapy for epithelial ovarian cancer, Obstet Gynecol, 65, 60

Peters, 1986, Salvage therapy with whole-abdominal irradiation in patients with advanced carcinoma of the ovary previously treated by combination chemotherapy, Cancer, 58, 880, 10.1002/1097-0142(19860815)58:4<880::AID-CNCR2820580413>3.0.CO;2-Z

Redman, 1986, Prognostic factors in advanced ovarian carcinoma, J Clin Oncol, 4, 515, 10.1200/JCO.1986.4.4.515

Swenerton, 1985, Ovarian carcinoma: a multivariate analysis of prognostic factors, Obstet Gynecol, 65, 264

Joyeux, 1986, Aggressive regional surgery for advanced ovarian carcinoma, Cancer, 57, 142, 10.1002/1097-0142(19860101)57:1<142::AID-CNCR2820570129>3.0.CO;2-#

Myers, 1984, The use of intraperitoneal chemotherapy in the treatment of ovarian cancer, Semin Oncol, 11, 275

Markman, 1986, Ip chemotherapy employing a regimen of cisplatin, cytarabine, and bleomycin, Cancer Treat Rep, 70, 755